ES2000863A6 - Metodo para preparar tabletas estables de aspirina sodica, aglomeranteanhidro y aceite mineral o vegetal hidrogenado. - Google Patents

Metodo para preparar tabletas estables de aspirina sodica, aglomeranteanhidro y aceite mineral o vegetal hidrogenado.

Info

Publication number
ES2000863A6
ES2000863A6 ES8601036A ES8601036A ES2000863A6 ES 2000863 A6 ES2000863 A6 ES 2000863A6 ES 8601036 A ES8601036 A ES 8601036A ES 8601036 A ES8601036 A ES 8601036A ES 2000863 A6 ES2000863 A6 ES 2000863A6
Authority
ES
Spain
Prior art keywords
compositions
aspirin
sodium aspirin
tablet compositions
stable sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8601036A
Other languages
English (en)
Inventor
Fred P Ducatman
John D Flanagan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacontrol Corp
Original Assignee
Pharmacontrol Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacontrol Corp filed Critical Pharmacontrol Corp
Publication of ES2000863A6 publication Critical patent/ES2000863A6/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

EL METODO DESCRITO PREPARA TABLETAS ESTABLES DE ASPIRINA SODICA MEZCLANDO ASPIRINA SODICA CRISTALINA SECA, UN AGLOMERANTE ANHIDRO Y UN LUBRICANTE DE ACEITE ANIMAL O VEGETAL DE ACIDOS GRASOS LIBRES, Y PRENSANDO LA MEZCLA EN FORMA DE TABLETAS. LAS FASES DE MEZCLADO Y TRANSFORMACION EN TABLETAS TIENEN LUGAR EN INSTALACIONES CON NO MAS DEL 30% DE HUMEDAD RELATIVA Y PREFERIBLEMENTE CON MENOS DEL 20% DE HUMEDAD RELATIVA. LAS TABLETAS PRODUCIDAS PUEDEN ALMACENARSE DURANTE PROLONGADOS PERIODOS DE TIEMPO Y, NO OBSTANTE, DESINTEGRARSE EN AGUA A UN REGIMEN COMPARABLE AL DE LA ASPIRINA ORDINARIA.
ES8601036A 1985-08-13 1986-08-12 Metodo para preparar tabletas estables de aspirina sodica, aglomeranteanhidro y aceite mineral o vegetal hidrogenado. Expired ES2000863A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/765,086 US4686212A (en) 1985-08-13 1985-08-13 Stable sodium aspirin tablet compositions

Publications (1)

Publication Number Publication Date
ES2000863A6 true ES2000863A6 (es) 1988-03-16

Family

ID=25072608

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8601036A Expired ES2000863A6 (es) 1985-08-13 1986-08-12 Metodo para preparar tabletas estables de aspirina sodica, aglomeranteanhidro y aceite mineral o vegetal hidrogenado.

Country Status (7)

Country Link
US (1) US4686212A (es)
EP (1) EP0213761A3 (es)
JP (1) JPS6289619A (es)
DK (2) DK383786A (es)
ES (1) ES2000863A6 (es)
NO (1) NO863254L (es)
WO (1) WO1988007859A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1112177A (ja) 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
JP4729149B2 (ja) 1997-06-25 2011-07-20 帝國製薬株式会社 安定なアスピリン軟膏製剤
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
FR2769580B1 (fr) 1997-10-09 1999-12-31 Lacroix Soc E Dispositif de leurrage a l'encontre des torpilles a remontee de sillage
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
HK1041217A1 (zh) * 1998-08-04 2002-07-05 藤泽药品工业株式会社 β-内酰胺抗生素的稳定化制剂
US6635278B1 (en) 1998-12-15 2003-10-21 Gilead Sciences, Inc. Pharmaceutical formulations
WO2002002081A1 (en) * 2000-07-05 2002-01-10 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and methods of using same
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
EP1429745A2 (en) 2001-09-28 2004-06-23 McNEIL-PPC, INC. Composite dosage forms having an inlaid portion
US7217381B2 (en) * 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
ATE495732T1 (de) 2003-03-26 2011-02-15 Egalet As Morphin-system mit kontrollierter freisetzung
US20050031683A1 (en) * 2003-08-04 2005-02-10 Ashish Kapoor Solid pharmaceutical composition
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
EP2034953A4 (en) * 2006-06-26 2013-05-15 Capricorn Pharma Inc ORAL DISINTEGRATING LAYER COMPOSITIONS
EP2155167A2 (en) 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
CA2715350C (en) * 2008-03-19 2017-02-14 Ratiopharm Gmbh Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic
EP2393484A1 (en) 2009-02-06 2011-12-14 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
EP2445487A2 (en) 2009-06-24 2012-05-02 Egalet Ltd. Controlled release formulations
NZ584497A (en) * 2010-04-08 2013-03-28 Symansis Ltd Assay system which includes an evaporation or freezing step

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197370A (en) * 1961-02-06 1965-07-27 Merck & Co Inc Pyrilamine tannate compositions
US3985792A (en) * 1971-12-23 1976-10-12 Alexander Galat Stable sodium acetylsalicylate and method for its manufacture
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
JPS53136515A (en) * 1977-04-28 1978-11-29 Lion Dentifrice Co Ltd Acetysalycylic acid solid preparation
JPS5547618A (en) * 1978-10-02 1980-04-04 Lion Corp Preparation of multilayered tablet containing acetylsalicylic acid or its derivative
AU531211B2 (en) * 1979-08-23 1983-08-11 E.I. Du Pont De Nemours And Company Nalbuphine composition
US4282215A (en) * 1980-06-17 1981-08-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetylsalicylic acid, derivative or salt thereof
JPS6033408B2 (ja) * 1979-11-20 1985-08-02 ライオン株式会社 アセチルサリチル酸錠剤
JPS5677223A (en) * 1979-11-27 1981-06-25 Lion Corp Acetylsalicylic acid tablet
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
DE3421735A1 (de) * 1984-06-12 1985-12-12 Klinge Pharma GmbH, 8000 München Einbettungsmasse fuer hydrolyseempfindliche arzneimittelwirkstoffe

Also Published As

Publication number Publication date
US4686212A (en) 1987-08-11
WO1988007859A1 (en) 1988-10-20
NO863254L (no) 1987-02-16
EP0213761A3 (en) 1988-10-05
JPH0535129B2 (es) 1993-05-25
DK383786D0 (da) 1986-08-12
NO863254D0 (no) 1986-08-12
EP0213761A2 (en) 1987-03-11
JPS6289619A (ja) 1987-04-24
DK8603837A (es) 1987-02-14
DK383786A (da) 1987-02-14

Similar Documents

Publication Publication Date Title
ES2000863A6 (es) Metodo para preparar tabletas estables de aspirina sodica, aglomeranteanhidro y aceite mineral o vegetal hidrogenado.
DE3872666D1 (de) Schmiermittelzusammensetzung zur verminderung des brennstoffverbrauchs.
DE3569368D1 (en) Angiotensin converting enzyme inhibitors and their production and use as pharmaceuticals
DK165909C (da) Tabletpresse til fremstilling af tabletter med overtraek
ES2021143B3 (es) Proceso mejorado para preparar composiciones oleaginosas estables.
DE3788629D1 (de) Neue malonsäurederivate und zusammensetzungen, die sie enthalten, zur verzögerung des pflanzenwachstums.
MY101750A (en) Improvements in or relating to calcium salts.
MD872G2 (ro) Compoziţie farmaceutică efervescentă şi preparat pe baza ei, procedeu de fabricare a preparatului
AR242495A1 (es) Receptaculo para portar protesis dental.
PH25418A (en) Improvements in, relating to effervescent acetyksalicylic acid tablets
DE2963990D1 (en) Analgesic tablet and process for its preparation
NZ183323A (en) Administration of enzyme composition to livestock to promote milk production
ES8605676A1 (es) Formulacion de acido acetilsalicilico con efecto retardado
ZA837164B (en) Bactericidal tabletting composition and tablets formed therefrom
DE3273577D1 (en) Improvements in or relating to coal gasification plant
ES8402153A1 (es) Un procedimiento para preparar una composicion solida comprimida para la limpieza de dentaduras postizas.
JPS57144215A (en) Composition for improving lipometabolism
ES2113803A1 (es) Metodo para el tratamiento de plantas.
JPS5566507A (en) Preparation of foamed tablet
IT8719190A0 (it) Procedimento per iniziare automaticamente la colata di una barra di impianti per colata continua.
HUP9602470A2 (hu) Captopril tartalmú tabletták és eljárás ezek előállítására
GB1427710A (en) Disinfectant compositions
ES2061932T3 (es) Compuestos de teluro y derivados de selenio.
ZA888097B (en) Phthalazineacetic acid composition and tablet
IT8122133A0 (it) Composizione farmaceutica di fosfomicina in compresse da succhiare.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001204